Robert L Jacobs
Overview
Explore the profile of Robert L Jacobs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramirez R, Jacobs R, Andrews C
Allergy Asthma Proc
. 2022 Mar;
43(2):116-123.
PMID: 35317888
Oak and birch pollens are strongly cross-reactive. It is unknown how robust this cross-reactivity is in patients without natural exposure to pollen of both trees. We assessed the symptom response...
2.
Smith A, Ramirez R, Harper N, Jimenez F, Branum A, Meunier J, et al.
Allergy
. 2021 Oct;
77(6):1797-1814.
PMID: 34606106
Background: Allergic asthma (AA) and allergic rhinoconjunctivitis (ARC) are common comorbid environmentally triggered diseases. We hypothesized that severe AA/ARC reflects a maladaptive or unrestrained response to ubiquitous aeroallergens. Methods: We...
3.
Pfaar O, Bergmann K, Bonini S, Compalati E, Domis N, de Blay F, et al.
Allergy
. 2021 May;
76(12):3589-3612.
PMID: 34028057
Allergen exposure chambers (AECs) can be used for controlled exposure to allergenic and non-allergenic airborne particles in an enclosed environment, in order to (i) characterize the pathological features of respiratory...
4.
Smith A, Harper N, Meunier J, Branum A, Jimenez F, Pandranki L, et al.
J Allergy Clin Immunol
. 2021 Jan;
148(2):533-549.
PMID: 33493557
Background: Signifying the 2-compartments/1-disease paradigm, allergic rhinoconjunctivitis (ARC) and asthma (AA) are prevalent, comorbid conditions triggered by environmental factors (eg, house dust mites [HDMs]). However, despite the ubiquity of triggers,...
5.
Hampel F, Pedinoff A, Jacobs R, Caracta C, Tantry S
Allergy Asthma Proc
. 2019 May;
40(4):261-272.
PMID: 31053180
GSP301 is an investigational fixed-dose combination nasal spray that contains the antihistamine, olopatadine hydrochloride (HCl), and the corticosteroid, mometasone furoate. To evaluate the efficacy and safety of GSP301 in patients...
6.
Jacobs M, Andrews C, Ramirez R, Jacobs R
Ann Allergy Asthma Immunol
. 2019 May;
123(2):201-207.
PMID: 31042573
Background: A variety of antigens have been identified as causative of hypersensitivity pneumonitis (HP), which is characterized by inflammation to the lung parenchyma that is induced by exposure. Goose and...
7.
Ellis A, Jacobs R, Tenn M, Steacy L, Adams D, Walker T, et al.
Ann Allergy Asthma Immunol
. 2019 Mar;
122(6):639-646.e2.
PMID: 30878629
Background: Controlled allergen challenge facilities (CACF), in disparate geographic regions with dissimilar engineering and base populations, have historically functioned as single, independent sites in clinical allergy trials. We aimed to...
8.
Jacobs R, Ramirez D, Rather C, Andrews C, Jupiter D, Trujillo F, et al.
Ann Allergy Asthma Immunol
. 2016 Dec;
118(1):86-93.e2.
PMID: 28007090
Background: There are few direct data concerning symptom dynamics of allergic conjunctivitis (AC) in an allergen challenge chamber (ACC). Objective: To determine the AC dynamics on subsequent exposures to ragweed...
9.
Ahuja S, Manoharan M, Harper N, Jimenez F, Hobson B, Martinez H, et al.
J Allergy Clin Immunol
. 2016 Sep;
139(3):844-854.
PMID: 27658763
Background: An emerging paradigm holds that resistance to the development of allergic diseases, including allergic rhinoconjunctivitis, relates to an intact epithelial/epidermal barrier during early childhood. Conceivably, the immunologic and genomic...
10.
Jacobs M, Jacobs R
J Allergy Clin Immunol Pract
. 2016 Feb;
4(3):537-8.
PMID: 26883542
No abstract available.